Takeda to buy Swiss drugmaker Nycomed for $13.7 billion
TOKYO/LONDON (Reuters) - Japan's largest drugmaker Takeda Pharmaceutical is buying privately held Nycomed for 9.6 billion euros ($13.7 billion), boosting its presence in emerging markets and adding a newly approved lung-disease drug.
James Topham and Ben Hirschler
TOKYO/LONDON
Thu May 19, 2011 8:53am EDT
link-
http://www.reuters.com/article/2011/05/19/us-takeda-nycomed-idUSTRE74I15620110519